Dell’Ova, M., De Maio, E., Guiu, S., Roca, L., Dalenc, F., Durigova, A., . . . Pouderoux, S. (2015). Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: Results from the ERIBEX retrospective, international, multicenter study. BMC Cancer.
Citação norma ChicagoDell’Ova, Mélodie, et al. "Tumour Biology, Metastatic Sites and Taxanes Sensitivity As Determinants of Eribulin Mesylate Efficacy in Breast Cancer: Results From the ERIBEX Retrospective, International, Multicenter Study." BMC Cancer 2015.
MLA CitationDell’Ova, Mélodie, et al. "Tumour Biology, Metastatic Sites and Taxanes Sensitivity As Determinants of Eribulin Mesylate Efficacy in Breast Cancer: Results From the ERIBEX Retrospective, International, Multicenter Study." BMC Cancer 2015.